[Recent advances in individualized treatment for pediatric high-risk B-cell acute lymphoblastic leukemia]
{{output}}
B-cell acute lymphoblastic leukemia (B-ALL) is the most common hematologic malignancy in children. High-risk B-ALL, due to factors such as poor early treatment response and adverse genetic features, is prone to drug resistance and relapse, resulting in an unfa... ...